Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo.
about
Characteristic differences between the promoters of intron-containing and intronless ribosomal protein genes in yeast.Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neuronsHit selection with false discovery rate control in genome-scale RNAi screensMicroRNA-127 modulates fetal lung developmentAn RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAiAnnexin A2 interactions with Rab14 in alveolar type II cellsRNA interference for alpha-ENaC inhibits rat lung fluid absorption in vivo(Pro)renin receptor contributes to regulation of renal epithelial sodium channel.Primer extension-based method for the generation of a siRNA/miRNA expression vector.Construction of siRNA/miRNA expression vectors based on a one-step PCR processViral-based modelling and correction of neurodegenerative diseases by RNA interference.Cell type specific, traceable gene silencing for functional gene analysis during vertebrate neural development.Characterization of the cell of origin for small cell lung cancerA pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells.Phosphodiesterase 5a Inhibition with Adenoviral Short Hairpin RNA Benefits Infarcted Heart Partially through Activation of Akt Signaling Pathway and Reduction of Inflammatory CytokinesA novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected].Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarctionA new design of a lentiviral shRNA vector with inducible co-expression of ARGONAUTE 2 for enhancing gene silencing efficiency.Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases.Genomics and proteomics approaches in understanding tumor angiogenesis.Short hairpin RNA interference therapy for ischemic heart diseaseAntisense gene silencing: therapy for neurodegenerative disorders?Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.Inhibition of Bcl-2 expression by a novel tumor-specific RNA interference system increases chemosensitivity to 5-fluorouracil in Hela cells.The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ.A novel function of ionotropic gamma-aminobutyric acid receptors involving alveolar fluid homeostasis.Defining a standard and weighted mathematical index for maturation of dendritic cells.A novel conditional gene silencing method using a tumor-specific and heat-inducible siRNA system.
P2860
Q21202155-51474B5C-5FD9-41ED-AA4B-DB6925A9EE8BQ24646447-AC1E9C4D-3419-4AED-B173-FD117412F07DQ24647185-5CAB684E-5FA9-4328-9C8B-E12CA1FAE326Q24657624-CD8F33DC-D528-464C-9201-3D616F9E3747Q24806293-16640327-D310-4314-AFA7-DD9A4F6744D9Q28570593-D9449510-564F-4395-8801-CB94C10747C5Q28572413-4684B1DE-1758-4397-8300-33D24D449787Q30277745-7FAD5FCA-0F1D-4BC2-9246-8E1CF06F5AAEQ33297459-48EDE2C5-60C5-4EAB-BDF7-3E5A46653DDBQ33458933-5966AD5B-522D-4552-BCAE-4DC333915490Q34471754-5E597F3E-B57F-401A-AC9C-CD115A09EA35Q35468232-DA25E7E7-2DEB-4185-8E94-80D598B8A216Q35559970-1C4D1683-CDE6-462F-86FD-413CD5067D73Q35721444-FA4E21FE-FD65-40CC-ADEB-06FED7A886F0Q35879351-5FF109AB-A2A6-44B4-9B94-6BFBE7C6894BQ35914149-814DF0B2-4B7A-4FF8-B24D-7D94F1624226Q35994136-B982632B-E908-4B67-AEAD-34E795341DC9Q36354182-715CC719-59C4-4A4E-8491-6FC58CFC8580Q36565686-76D20DE2-44FB-41C1-8AEC-A0BCC1CF5EC3Q36748498-85D8CB08-3F63-433C-B32A-BBFB3AB5E2B5Q36853941-03DFBE81-0EC3-46BF-A953-D3141D40D9E5Q37585001-0D9AFF04-02AA-4C48-8D79-F5C1702A2D86Q38614156-E80E186D-8A6F-47D9-ADBA-8FFCF21B944CQ39345292-F3C149A5-32F5-4CD3-B129-7A5F9FC63CEDQ40330010-1AFE8B84-40F9-47DE-9D19-FB56C1964195Q40512435-7F495715-81C0-4815-874A-5B26194F50AAQ42501858-FCDF447D-E097-4F9A-98E1-E32D0E9DEC0AQ47412496-A7243F0C-89DC-41D0-8D24-2CC8BF940A85Q54663468-8CE41A80-01EC-4655-BBE9-FC2C01C1D7AC
P2860
Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gene silencing in alveolar typ ...... promoter in vitro and in vivo.
@en
type
label
Gene silencing in alveolar typ ...... promoter in vitro and in vivo.
@en
prefLabel
Gene silencing in alveolar typ ...... promoter in vitro and in vivo.
@en
P2093
P2860
P356
P1476
Gene silencing in alveolar typ ...... promoter in vitro and in vivo.
@en
P2093
Deming Gou
Narendranath Reddy Chintagari
Pengcheng Wang
Telugu Narasaraju
P2860
P356
10.1093/NAR/GNH129
P577
2004-09-27T00:00:00Z